Myotonic Dystrophy Family Registry
Launched by MYOTONIC DYSTROPHY FOUNDATION · Mar 24, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Myotonic Dystrophy Family Registry (MDFR) is an online program designed to gather information about myotonic dystrophy, a genetic condition that affects muscle function. By collecting data from people diagnosed with different forms of myotonic dystrophy, this registry aims to help researchers find better treatments and identify individuals who might want to participate in research studies or clinical trials. This program is currently recruiting participants of all ages who have been diagnosed with congenital, juvenile-onset, or adult-onset forms of myotonic dystrophy (DM1 or DM2).
To join the registry, you need to have a confirmed diagnosis of myotonic dystrophy, either through a medical exam or genetic testing. Unfortunately, if you do not have this condition or if you are an unaffected family member, you won’t be eligible to participate. By joining, you’ll be contributing valuable information that can help advance research in this area, and you can expect to share your experiences and health information through an easy-to-use online platform. Your participation could make a meaningful difference in the lives of others affected by this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with congenital, juvenile-onset or adult onset DM1 or DM2 (confirmed by clinical exam or genetic test)
- Exclusion Criteria:
- • Not diagnosed with DM, unaffected family members
About Myotonic Dystrophy Foundation
The Myotonic Dystrophy Foundation (MDF) is a leading nonprofit organization dedicated to advancing research, advocacy, and support for individuals affected by myotonic dystrophy, a complex and progressive genetic disorder. By fostering collaboration among researchers, healthcare professionals, and the myotonic dystrophy community, the MDF aims to accelerate the development of effective treatments and improve the quality of life for patients. Through funding innovative clinical trials, promoting awareness, and providing educational resources, the foundation plays a pivotal role in transforming the landscape of myotonic dystrophy care and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oakland, California, United States
Patients applied
Trial Officials
Tanya Stevenson, EdD, MPH
Study Chair
Myotonic Dystrophy Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials